首页> 外文期刊>International Journal of Surgery Case Reports >Signet ring cell carcinoma of the ampulla of vater: Report of a case and a review of the literature
【24h】

Signet ring cell carcinoma of the ampulla of vater: Report of a case and a review of the literature

机译:迷走壶腹印戒细胞癌:一例报告并文献复习

获取原文
           

摘要

Introduction: Signet ring cell carcinoma (SRCC) of the ampulla of vater is a very rare tumor that is reported infrequently in the literature. Presentation of case: A 59-year-old woman visited our hospital for evaluation of elevated transaminase levels. On laboratory examination of tumor marker levels, carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 levels were normal, and DUPAN-2 was elevated. Computed tomography (CT) confirmed a 2cm, enhanced mass in the periampullary region, with marked common bile duct dilatation. Endoscopic retrograde cholangiopancreatography (ERCP) showed a swollen papilla of vater, with a reddish, erosive mucosa. Histological examination of biopsy samples from the ampulla of vater showed signet ring cell carcinoma (SRCC). The patient underwent radical pancreatoduodenectomy. Pathological examination showed that the SRCC had infiltrated into the duodenal muscularis propria and pancreatic parenchyma, and lymph node metastases were identified around the abdominal aorta and common hepatic artery. Based on the immunohistochemical staining patterns of the positive results for CDX2 and MUC2, the tumor cells in the present case appeared to have an intestinal type origin. The ampullary cancer was diagnosed as T3bN1M1, Stage IV according to the International Union Against Cancer TNM classification (UICC). After undergoing adjuvant chemotherapy with cisplatin-gemcitabine chemotherapy for 6 months, the patient has remained disease-free in the 7 months since surgery. Discussion: SRCC of intestinal-type origin is associated with a favorable outcome. Conclusion: Investigation to confirm the histological origin of SRCC by immunohistochemical staining might inform the treatment strategy and identify patients with ampullary SRCC who may have a good prognosis.
机译:简介:壶腹的印戒细胞癌(SRCC)是一种非常罕见的肿瘤,文献中很少报道。病例介绍:一名59岁的妇女前往我院评估转氨酶水平升高。在实验室检查肿瘤标志物水平时,癌胚抗原(CEA)和碳水化合物抗原(CA)的19-9水平正常,而DUPAN-2升高。计算机体层摄影术(CT)证实壶腹周围区域质量增加了2cm,并伴有胆总管扩张。内镜逆行胰胆管造影(ERCP)显示肿胀的乳头状乳头,带红色糜烂性粘膜。的壶腹活检标本的组织学检查显示为印戒细胞癌(SRCC)。该患者接受了根治性胰十二指肠切除术。病理检查表明,SRCC已渗入十二指肠固有肌和胰腺实质,并在腹主动脉和肝总动脉周围发现淋巴结转移。基于CDX2和MUC2阳性结果的免疫组织化学染色模式,本例中的肿瘤细胞似乎具有肠道类型起源。根据国际抗癌联盟TNM分类(UICC),壶腹癌被诊断为IV期T3bN1M1。在接受了顺铂-吉西他滨化疗的辅助化疗6个月后,患者在手术后的7个月内一直保持无病。讨论:肠源性SRCC与良好的预后相关。结论:通过免疫组织化学染色证实SRCC的组织学起源可能为治疗策略和确定壶腹SRCC患者预后提供依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号